Skip to main content
. 2014 Mar 6;1(2):180–182. doi: 10.18632/oncoscience.18

Fig 2. A TBK1/IKKε inhibitor (TBK1-II) cooperates with the EGFR/HER2 inhibitor (lapatinib) to further promote apoptotic cell death, but not cellular senescence.

Fig 2